Current Opinion in Psychiatry · 2003 · 13 citations · 31 references
Social SciencesBehavioral SciencesPsychiatryAbnormal PsychologyNeuropsychiatryNeuropsychologyAnxiety DisordersAnxiety SymptomsNeuropsychiatric DisordersObsessive-compulsive DisordersSerotonergic PharmacologyComorbidity With Obsessive-compulsive DisorderCompulsive DisordersMood Disorders DiagnosisNeuropsychiatric ManifestationsSensory AbnormalitiesSensory-motor Function
The symptoms of obsessive-compulsive disorder comprise various obsessions and compulsions with rituals, sensory abnormalities, doubts, overvalued ideas, speech abnormalities, emotional disturbances (depression, anxiety, irritability and others), immediate memory deficits and minor (soft) neurological signs. Actually, obsessive-compulsive disorder is a heterogeneous syndrome that includes subtypes that overlap with both anxiety and mood disorders. Although new findings on obsessive-compulsive disorder allow the development of theories on the etiology and suggest therapeutic approaches, new pathways are still being sought to explain the intriguing enigma of obsessions. The search for biological markers in obsessive-compulsive disorder is relatively new, as most literature in this field has been produced in the past decade. The major hypothesis on the pathophysiology of obsessive-compulsive disorder relates to serotonin (5-hydroxytryptamine), on the basis of an almost exclusive response to serotonergic drugs by patients with the disorder. Furthermore, in recent years a growing number of neuropsychiatric studies have documented an impairment in both cognitive and sensory motor functions in obsessive-compulsive disorder. Together with neuroimaging studies and neurosurgical research, some neuroanatomical models of obsessive-compulsive disorder have been developed. These models have focused on reciprocal connections between frontal cortex and basal ganglia. Advances in brain-imaging techniques (positron emission tomography (PET), single-photon computed tomography, magnetoencephalography, functional magnetic resonance) and the development of specific radiolabeled serotonergic ligands should allow the in-vivo visualization of structure-function relationship, and may lead to a better understanding of this illness.
31